MetLife Investment Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.7M | Buy |
71,120
+947
| +1% | +$49.3K | 0.02% | 700 |
|
|
2025
Q1 | $2.99M | Sell |
70,173
-1,976
| -3% | -$84.2K | 0.02% | 853 |
|
|
2024
Q4 | $2.2M | Buy |
72,149
+4,002
| +6% | +$122K | 0.01% | 985 |
|
|
2024
Q3 | $1.56M | Hold |
68,147
| – | – | 0.01% | 1151 |
|
|
2024
Q2 | $1.97M | Buy |
68,147
+9,542
| +16% | +$276K | 0.01% | 980 |
|
|
2024
Q1 | $1.21M | Hold |
58,605
| – | – | 0.01% | 1197 |
|
|
2023
Q4 | $1.59M | Hold |
58,605
| – | – | 0.01% | 1057 |
|
|
2023
Q3 | $1.74M | Hold |
58,605
| – | – | 0.01% | 966 |
|
|
2023
Q2 | $2.1M | Buy |
58,605
+52,701
| +893% | +$1.89M | 0.02% | 916 |
|
|
2023
Q1 | $138K | Buy |
5,904
+13
| +0.2% | +$305 | ﹤0.01% | 2420 |
|
|
2022
Q4 | $160K | Sell |
5,891
-155
| -3% | -$4.22K | ﹤0.01% | 2381 |
|
|
2022
Q3 | $325K | Buy |
6,046
+5
| +0.1% | +$269 | ﹤0.01% | 1944 |
|
|
2022
Q2 | $244K | Buy |
6,041
+230
| +4% | +$9.28K | ﹤0.01% | 2175 |
|
|
2022
Q1 | $385K | Buy |
+5,811
| New | +$385K | ﹤0.01% | 1943 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2287 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 2317 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2319 |
|
|
2020
Q1 | – | Sell |
-3,147
| Closed | -$246K | – | 2266 |
|
|
2019
Q4 | $246K | Buy |
+3,147
| New | +$246K | ﹤0.01% | 1868 |
|
|
2019
Q3 | – | Sell |
-6,515
| Closed | -$562K | – | 2355 |
|
|
2019
Q2 | $562K | Hold |
6,515
| – | – | 0.01% | 1410 |
|
|
2019
Q1 | $500K | Sell |
6,515
-2,107
| -24% | -$162K | 0.01% | 1454 |
|
|
2018
Q4 | $324K | Buy |
+8,622
| New | +$324K | ﹤0.01% | 1626 |
|